Fast Improvements of Acute Inflammatory Symptomatology in Patients With Hand Osteoarthritis With the Use of Doxycycline. Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.21203/rs.3.rs-3511645/v1
Background: Osteoarthritis (OA) presents the high activity of free radicals and proteolytic enzymes which were inhibited by Doxycycline (DOX). Objective : To search the efficacy, safety, and fastness for the improvement of inflammatory signs in patients with Hand Osteoarthritis (HOA). Methodology: Randomized, placebo-controlled trial during four weeks with two groups of patients: DOX group using one tablet of 100 mg bid per os; control group using paracetamol bid per os ; the data were obtained through Visual Analog Scale (VAS) evaluation for pain, flushing/edema by the patient and the examiner; the primary outcome was the improvement greater than 50% from the basal values after four weeks . Results: Thirty-eight female patients with HOA after menopause were allocated: 20 in the DOX group and 18 in the control group. The results showed that the DOX group presented a significant improvement in 75% of patients compared to the control group (p <0.00000), which started after 6.05 ± 3.7 days of treatment; and mild adverse effects in 20% of the sample - gastric pain, nausea, vomiting after 9.0 ± 5.2 days without any removal from the trial. Compared to the baseline and the control group results, was observed a significant improvement in pain (p <0.00000) and edema/flushing (p<0.00000) demonstrated the efficacy of inflammation; no abnormality was seen on the blood analysis, and no hematological, renal, cardiologic and hepatic commitment. Conclusion: Doxycycline by a short length of time was safe and improved the pain and inflammatory signs of HOA.
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.21203/rs.3.rs-3511645/v1
- https://www.researchsquare.com/article/rs-3511645/latest.pdf
- OA Status
- green
- References
- 24
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4388044461
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4388044461Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.21203/rs.3.rs-3511645/v1Digital Object Identifier
- Title
-
Fast Improvements of Acute Inflammatory Symptomatology in Patients With Hand Osteoarthritis With the Use of Doxycycline.Work title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-10-31Full publication date if available
- Authors
-
Mário Newton Leitão de Azevedo, Marco Antonio Cullar Arnez, Ingrid Bandeira Moss, Breno Valdetaro Bianchi, Blance Elena Rios Gomes BicaList of authors in order
- Landing page
-
https://doi.org/10.21203/rs.3.rs-3511645/v1Publisher landing page
- PDF URL
-
https://www.researchsquare.com/article/rs-3511645/latest.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.researchsquare.com/article/rs-3511645/latest.pdfDirect OA link when available
- Concepts
-
Medicine, Nausea, Osteoarthritis, Vomiting, Placebo, Edema, Randomized controlled trial, Visual analogue scale, Anesthesia, Adverse effect, Doxycycline, Surgery, Internal medicine, Gastroenterology, Antibiotics, Microbiology, Pathology, Alternative medicine, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
24Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4388044461 |
|---|---|
| doi | https://doi.org/10.21203/rs.3.rs-3511645/v1 |
| ids.doi | https://doi.org/10.21203/rs.3.rs-3511645/v1 |
| ids.openalex | https://openalex.org/W4388044461 |
| fwci | 0.0 |
| type | preprint |
| title | Fast Improvements of Acute Inflammatory Symptomatology in Patients With Hand Osteoarthritis With the Use of Doxycycline. |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10105 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9718000292778015 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2745 |
| topics[0].subfield.display_name | Rheumatology |
| topics[0].display_name | Osteoarthritis Treatment and Mechanisms |
| topics[1].id | https://openalex.org/T11282 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9527999758720398 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2738 |
| topics[1].subfield.display_name | Psychiatry and Mental health |
| topics[1].display_name | Fibromyalgia and Chronic Fatigue Syndrome Research |
| topics[2].id | https://openalex.org/T10678 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9361000061035156 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2736 |
| topics[2].subfield.display_name | Pharmacology |
| topics[2].display_name | Inflammatory mediators and NSAID effects |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8127747774124146 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780580376 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6582385897636414 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q186889 |
| concepts[1].display_name | Nausea |
| concepts[2].id | https://openalex.org/C2776164576 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6386862993240356 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q62736 |
| concepts[2].display_name | Osteoarthritis |
| concepts[3].id | https://openalex.org/C2780852908 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5960986614227295 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q127076 |
| concepts[3].display_name | Vomiting |
| concepts[4].id | https://openalex.org/C27081682 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5780090689659119 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[4].display_name | Placebo |
| concepts[5].id | https://openalex.org/C2780886150 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5736163854598999 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q152234 |
| concepts[5].display_name | Edema |
| concepts[6].id | https://openalex.org/C168563851 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5059563517570496 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[6].display_name | Randomized controlled trial |
| concepts[7].id | https://openalex.org/C14184104 |
| concepts[7].level | 2 |
| concepts[7].score | 0.49805736541748047 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1362526 |
| concepts[7].display_name | Visual analogue scale |
| concepts[8].id | https://openalex.org/C42219234 |
| concepts[8].level | 1 |
| concepts[8].score | 0.49677926301956177 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q131130 |
| concepts[8].display_name | Anesthesia |
| concepts[9].id | https://openalex.org/C197934379 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4926770329475403 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[9].display_name | Adverse effect |
| concepts[10].id | https://openalex.org/C2777179404 |
| concepts[10].level | 3 |
| concepts[10].score | 0.42756104469299316 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q422442 |
| concepts[10].display_name | Doxycycline |
| concepts[11].id | https://openalex.org/C141071460 |
| concepts[11].level | 1 |
| concepts[11].score | 0.38910192251205444 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[11].display_name | Surgery |
| concepts[12].id | https://openalex.org/C126322002 |
| concepts[12].level | 1 |
| concepts[12].score | 0.3499663174152374 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[12].display_name | Internal medicine |
| concepts[13].id | https://openalex.org/C90924648 |
| concepts[13].level | 1 |
| concepts[13].score | 0.327060341835022 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[13].display_name | Gastroenterology |
| concepts[14].id | https://openalex.org/C501593827 |
| concepts[14].level | 2 |
| concepts[14].score | 0.10640230774879456 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12187 |
| concepts[14].display_name | Antibiotics |
| concepts[15].id | https://openalex.org/C89423630 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[15].display_name | Microbiology |
| concepts[16].id | https://openalex.org/C142724271 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[16].display_name | Pathology |
| concepts[17].id | https://openalex.org/C204787440 |
| concepts[17].level | 2 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[17].display_name | Alternative medicine |
| concepts[18].id | https://openalex.org/C86803240 |
| concepts[18].level | 0 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[18].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8127747774124146 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/nausea |
| keywords[1].score | 0.6582385897636414 |
| keywords[1].display_name | Nausea |
| keywords[2].id | https://openalex.org/keywords/osteoarthritis |
| keywords[2].score | 0.6386862993240356 |
| keywords[2].display_name | Osteoarthritis |
| keywords[3].id | https://openalex.org/keywords/vomiting |
| keywords[3].score | 0.5960986614227295 |
| keywords[3].display_name | Vomiting |
| keywords[4].id | https://openalex.org/keywords/placebo |
| keywords[4].score | 0.5780090689659119 |
| keywords[4].display_name | Placebo |
| keywords[5].id | https://openalex.org/keywords/edema |
| keywords[5].score | 0.5736163854598999 |
| keywords[5].display_name | Edema |
| keywords[6].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[6].score | 0.5059563517570496 |
| keywords[6].display_name | Randomized controlled trial |
| keywords[7].id | https://openalex.org/keywords/visual-analogue-scale |
| keywords[7].score | 0.49805736541748047 |
| keywords[7].display_name | Visual analogue scale |
| keywords[8].id | https://openalex.org/keywords/anesthesia |
| keywords[8].score | 0.49677926301956177 |
| keywords[8].display_name | Anesthesia |
| keywords[9].id | https://openalex.org/keywords/adverse-effect |
| keywords[9].score | 0.4926770329475403 |
| keywords[9].display_name | Adverse effect |
| keywords[10].id | https://openalex.org/keywords/doxycycline |
| keywords[10].score | 0.42756104469299316 |
| keywords[10].display_name | Doxycycline |
| keywords[11].id | https://openalex.org/keywords/surgery |
| keywords[11].score | 0.38910192251205444 |
| keywords[11].display_name | Surgery |
| keywords[12].id | https://openalex.org/keywords/internal-medicine |
| keywords[12].score | 0.3499663174152374 |
| keywords[12].display_name | Internal medicine |
| keywords[13].id | https://openalex.org/keywords/gastroenterology |
| keywords[13].score | 0.327060341835022 |
| keywords[13].display_name | Gastroenterology |
| keywords[14].id | https://openalex.org/keywords/antibiotics |
| keywords[14].score | 0.10640230774879456 |
| keywords[14].display_name | Antibiotics |
| language | en |
| locations[0].id | doi:10.21203/rs.3.rs-3511645/v1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306402450 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Research Square (Research Square) |
| locations[0].source.host_organization | https://openalex.org/I4210096694 |
| locations[0].source.host_organization_name | Research Square (United States) |
| locations[0].source.host_organization_lineage | https://openalex.org/I4210096694 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.researchsquare.com/article/rs-3511645/latest.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.21203/rs.3.rs-3511645/v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5026017827 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0229-698X |
| authorships[0].author.display_name | Mário Newton Leitão de Azevedo |
| authorships[0].countries | BR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I122140584 |
| authorships[0].affiliations[0].raw_affiliation_string | Rheumatology Service - Universidade Federal do Rio de Janeiro |
| authorships[0].institutions[0].id | https://openalex.org/I122140584 |
| authorships[0].institutions[0].ror | https://ror.org/03490as77 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I122140584 |
| authorships[0].institutions[0].country_code | BR |
| authorships[0].institutions[0].display_name | Universidade Federal do Rio de Janeiro |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | MARIO NEWTON LEITAO DE AZEVEDO |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Rheumatology Service - Universidade Federal do Rio de Janeiro |
| authorships[1].author.id | https://openalex.org/A5111064751 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Marco Antonio Cullar Arnez |
| authorships[1].countries | BR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I122140584 |
| authorships[1].affiliations[0].raw_affiliation_string | Rheumatology Service -Universidade Federal do Rio de Janeiro Ingrid Bandeira Moss Rheumatology Service -Univesidade Federal do Rio de Janeiro |
| authorships[1].institutions[0].id | https://openalex.org/I122140584 |
| authorships[1].institutions[0].ror | https://ror.org/03490as77 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I122140584 |
| authorships[1].institutions[0].country_code | BR |
| authorships[1].institutions[0].display_name | Universidade Federal do Rio de Janeiro |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Marco Antonio Cullar Arnez |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Rheumatology Service -Universidade Federal do Rio de Janeiro Ingrid Bandeira Moss Rheumatology Service -Univesidade Federal do Rio de Janeiro |
| authorships[2].author.id | https://openalex.org/A5074269833 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Ingrid Bandeira Moss |
| authorships[2].countries | BR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I122140584 |
| authorships[2].affiliations[0].raw_affiliation_string | Rheumatology Service - Univesidade Federal do Rio de Janeiro |
| authorships[2].institutions[0].id | https://openalex.org/I122140584 |
| authorships[2].institutions[0].ror | https://ror.org/03490as77 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I122140584 |
| authorships[2].institutions[0].country_code | BR |
| authorships[2].institutions[0].display_name | Universidade Federal do Rio de Janeiro |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ingrid Bandeira Moss |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Rheumatology Service - Univesidade Federal do Rio de Janeiro |
| authorships[3].author.id | https://openalex.org/A5062320580 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Breno Valdetaro Bianchi |
| authorships[3].countries | BR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I122140584 |
| authorships[3].affiliations[0].raw_affiliation_string | Rheumatology Service - Universidade Federal do Rio de Janeiro |
| authorships[3].institutions[0].id | https://openalex.org/I122140584 |
| authorships[3].institutions[0].ror | https://ror.org/03490as77 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I122140584 |
| authorships[3].institutions[0].country_code | BR |
| authorships[3].institutions[0].display_name | Universidade Federal do Rio de Janeiro |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Breno Valdetaro Bianchi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Rheumatology Service - Universidade Federal do Rio de Janeiro |
| authorships[4].author.id | https://openalex.org/A5108873846 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Blance Elena Rios Gomes Bica |
| authorships[4].countries | BR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I122140584 |
| authorships[4].affiliations[0].raw_affiliation_string | Rheumatology Service -Universidade Federal do Rio de Janeiro Research |
| authorships[4].institutions[0].id | https://openalex.org/I122140584 |
| authorships[4].institutions[0].ror | https://ror.org/03490as77 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I122140584 |
| authorships[4].institutions[0].country_code | BR |
| authorships[4].institutions[0].display_name | Universidade Federal do Rio de Janeiro |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Blance Elena Rios Gomes Bica |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Rheumatology Service -Universidade Federal do Rio de Janeiro Research |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.researchsquare.com/article/rs-3511645/latest.pdf |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Fast Improvements of Acute Inflammatory Symptomatology in Patients With Hand Osteoarthritis With the Use of Doxycycline. |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10105 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9718000292778015 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2745 |
| primary_topic.subfield.display_name | Rheumatology |
| primary_topic.display_name | Osteoarthritis Treatment and Mechanisms |
| related_works | https://openalex.org/W148728087, https://openalex.org/W2375265431, https://openalex.org/W2005374976, https://openalex.org/W2035319767, https://openalex.org/W2030053732, https://openalex.org/W1979418062, https://openalex.org/W2330828714, https://openalex.org/W2157228124, https://openalex.org/W2033508602, https://openalex.org/W2606466801 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.21203/rs.3.rs-3511645/v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402450 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Research Square (Research Square) |
| best_oa_location.source.host_organization | https://openalex.org/I4210096694 |
| best_oa_location.source.host_organization_name | Research Square (United States) |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I4210096694 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.researchsquare.com/article/rs-3511645/latest.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-3511645/v1 |
| primary_location.id | doi:10.21203/rs.3.rs-3511645/v1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306402450 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Research Square (Research Square) |
| primary_location.source.host_organization | https://openalex.org/I4210096694 |
| primary_location.source.host_organization_name | Research Square (United States) |
| primary_location.source.host_organization_lineage | https://openalex.org/I4210096694 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.researchsquare.com/article/rs-3511645/latest.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-3511645/v1 |
| publication_date | 2023-10-31 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2022439833, https://openalex.org/W2767479935, https://openalex.org/W2031503254, https://openalex.org/W2735263996, https://openalex.org/W2340390214, https://openalex.org/W2912280867, https://openalex.org/W3009853031, https://openalex.org/W2137295068, https://openalex.org/W1707356941, https://openalex.org/W2113905699, https://openalex.org/W2032185382, https://openalex.org/W2998906806, https://openalex.org/W1867175571, https://openalex.org/W2141363952, https://openalex.org/W2775287384, https://openalex.org/W3121798527, https://openalex.org/W2789625780, https://openalex.org/W2766714690, https://openalex.org/W3007068828, https://openalex.org/W2921039027, https://openalex.org/W1980424244, https://openalex.org/W2072961804, https://openalex.org/W4211172015, https://openalex.org/W2007720003 |
| referenced_works_count | 24 |
| abstract_inverted_index.- | 169 |
| abstract_inverted_index.. | 107 |
| abstract_inverted_index.: | 21 |
| abstract_inverted_index.; | 71 |
| abstract_inverted_index.a | 137, 196, 230 |
| abstract_inverted_index.(p | 149, 201 |
| abstract_inverted_index.18 | 124 |
| abstract_inverted_index.20 | 118 |
| abstract_inverted_index.To | 22 |
| abstract_inverted_index.by | 17, 85, 229 |
| abstract_inverted_index.in | 35, 119, 125, 140, 164, 199 |
| abstract_inverted_index.mg | 60 |
| abstract_inverted_index.no | 211, 220 |
| abstract_inverted_index.of | 8, 32, 51, 58, 142, 158, 166, 209, 233, 244 |
| abstract_inverted_index.on | 215 |
| abstract_inverted_index.os | 70 |
| abstract_inverted_index.to | 145, 186 |
| abstract_inverted_index.± | 155, 176 |
| abstract_inverted_index.100 | 59 |
| abstract_inverted_index.20% | 165 |
| abstract_inverted_index.3.7 | 156 |
| abstract_inverted_index.5.2 | 177 |
| abstract_inverted_index.50% | 99 |
| abstract_inverted_index.75% | 141 |
| abstract_inverted_index.9.0 | 175 |
| abstract_inverted_index.DOX | 53, 121, 134 |
| abstract_inverted_index.HOA | 113 |
| abstract_inverted_index.The | 129 |
| abstract_inverted_index.and | 11, 27, 88, 123, 160, 189, 203, 219, 224, 237, 241 |
| abstract_inverted_index.any | 180 |
| abstract_inverted_index.bid | 61, 68 |
| abstract_inverted_index.for | 29, 82 |
| abstract_inverted_index.one | 56 |
| abstract_inverted_index.os; | 63 |
| abstract_inverted_index.per | 62, 69 |
| abstract_inverted_index.the | 5, 24, 30, 72, 86, 89, 91, 95, 101, 120, 126, 133, 146, 167, 183, 187, 190, 207, 216, 239 |
| abstract_inverted_index.two | 49 |
| abstract_inverted_index.was | 94, 194, 213, 235 |
| abstract_inverted_index.(OA) | 3 |
| abstract_inverted_index.6.05 | 154 |
| abstract_inverted_index.HOA. | 245 |
| abstract_inverted_index.Hand | 38 |
| abstract_inverted_index.data | 73 |
| abstract_inverted_index.days | 157, 178 |
| abstract_inverted_index.four | 46, 105 |
| abstract_inverted_index.free | 9 |
| abstract_inverted_index.from | 100, 182 |
| abstract_inverted_index.high | 6 |
| abstract_inverted_index.mild | 161 |
| abstract_inverted_index.pain | 200, 240 |
| abstract_inverted_index.safe | 236 |
| abstract_inverted_index.seen | 214 |
| abstract_inverted_index.than | 98 |
| abstract_inverted_index.that | 132 |
| abstract_inverted_index.time | 234 |
| abstract_inverted_index.were | 15, 74, 116 |
| abstract_inverted_index.with | 37, 48, 112 |
| abstract_inverted_index.(VAS) | 80 |
| abstract_inverted_index.Scale | 79 |
| abstract_inverted_index.after | 104, 114, 153, 174 |
| abstract_inverted_index.basal | 102 |
| abstract_inverted_index.blood | 217 |
| abstract_inverted_index.group | 54, 65, 122, 135, 148, 192 |
| abstract_inverted_index.pain, | 83, 171 |
| abstract_inverted_index.short | 231 |
| abstract_inverted_index.signs | 34, 243 |
| abstract_inverted_index.trial | 44 |
| abstract_inverted_index.using | 55, 66 |
| abstract_inverted_index.weeks | 47, 106 |
| abstract_inverted_index.which | 14, 151 |
| abstract_inverted_index.(DOX). | 19 |
| abstract_inverted_index.(HOA). | 40 |
| abstract_inverted_index.Analog | 78 |
| abstract_inverted_index.Visual | 77 |
| abstract_inverted_index.during | 45 |
| abstract_inverted_index.female | 110 |
| abstract_inverted_index.group. | 128 |
| abstract_inverted_index.groups | 50 |
| abstract_inverted_index.length | 232 |
| abstract_inverted_index.renal, | 222 |
| abstract_inverted_index.sample | 168 |
| abstract_inverted_index.search | 23 |
| abstract_inverted_index.showed | 131 |
| abstract_inverted_index.tablet | 57 |
| abstract_inverted_index.trial. | 184 |
| abstract_inverted_index.values | 103 |
| abstract_inverted_index.adverse | 162 |
| abstract_inverted_index.control | 64, 127, 147, 191 |
| abstract_inverted_index.effects | 163 |
| abstract_inverted_index.enzymes | 13 |
| abstract_inverted_index.gastric | 170 |
| abstract_inverted_index.greater | 97 |
| abstract_inverted_index.hepatic | 225 |
| abstract_inverted_index.nausea, | 172 |
| abstract_inverted_index.outcome | 93 |
| abstract_inverted_index.patient | 87 |
| abstract_inverted_index.primary | 92 |
| abstract_inverted_index.removal | 181 |
| abstract_inverted_index.results | 130 |
| abstract_inverted_index.safety, | 26 |
| abstract_inverted_index.started | 152 |
| abstract_inverted_index.through | 76 |
| abstract_inverted_index.without | 179 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Compared | 185 |
| abstract_inverted_index.Results: | 108 |
| abstract_inverted_index.activity | 7 |
| abstract_inverted_index.baseline | 188 |
| abstract_inverted_index.compared | 144 |
| abstract_inverted_index.efficacy | 208 |
| abstract_inverted_index.fastness | 28 |
| abstract_inverted_index.improved | 238 |
| abstract_inverted_index.observed | 195 |
| abstract_inverted_index.obtained | 75 |
| abstract_inverted_index.patients | 36, 111, 143 |
| abstract_inverted_index.presents | 4 |
| abstract_inverted_index.radicals | 10 |
| abstract_inverted_index.results, | 193 |
| abstract_inverted_index.vomiting | 173 |
| abstract_inverted_index.Objective | 20 |
| abstract_inverted_index.analysis, | 218 |
| abstract_inverted_index.efficacy, | 25 |
| abstract_inverted_index.examiner; | 90 |
| abstract_inverted_index.inhibited | 16 |
| abstract_inverted_index.menopause | 115 |
| abstract_inverted_index.patients: | 52 |
| abstract_inverted_index.presented | 136 |
| abstract_inverted_index.allocated: | 117 |
| abstract_inverted_index.evaluation | 81 |
| abstract_inverted_index.treatment; | 159 |
| abstract_inverted_index.Background: | 1 |
| abstract_inverted_index.Conclusion: | 227 |
| abstract_inverted_index.Doxycycline | 18, 228 |
| abstract_inverted_index.Randomized, | 42 |
| abstract_inverted_index.abnormality | 212 |
| abstract_inverted_index.cardiologic | 223 |
| abstract_inverted_index.commitment. | 226 |
| abstract_inverted_index.improvement | 31, 96, 139, 198 |
| abstract_inverted_index.paracetamol | 67 |
| abstract_inverted_index.proteolytic | 12 |
| abstract_inverted_index.significant | 138, 197 |
| abstract_inverted_index.<0.00000) | 202 |
| abstract_inverted_index.Methodology: | 41 |
| abstract_inverted_index.Thirty-eight | 109 |
| abstract_inverted_index.demonstrated | 206 |
| abstract_inverted_index.inflammatory | 33, 242 |
| abstract_inverted_index.<0.00000), | 150 |
| abstract_inverted_index.inflammation; | 210 |
| abstract_inverted_index.(p<0.00000) | 205 |
| abstract_inverted_index.Osteoarthritis | 2, 39 |
| abstract_inverted_index.edema/flushing | 204 |
| abstract_inverted_index.flushing/edema | 84 |
| abstract_inverted_index.hematological, | 221 |
| abstract_inverted_index.placebo-controlled | 43 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.800000011920929 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.33310455 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |